Boehringer Ingelheim Launches Corporate VC Fund
Boehringer Ingelheim, a German pharmaceutical company, has launched a €100 million corporate venture fund. The vehicle will invest in startups "that provide ground-breaking therapeutic approaches and technologies to help drive innovation in medical science. "
31 March 2010•2 mins read
